Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the efficacy and safety of a three time repeated
loading dose of intravenous ibandronate (ibandronic acid), 6 mg, in breast cancer patients
with painful skeletal metastases.